November 29, 2010 A House committee investigation into Johnson & Johnson's spate of recent recalls continues for now, but when Republicans take over the committee in January, that could change.
There's a lot going on with the little blue pill called Truvada made by Gilead Sciences of Forest City, Calif.
November 23, 2010 A large study shows that men who took the pill Truvada nearly every day cut their risk of HIV infection by 73 percent. But those who took their pills half the time just cut their risk by 50 percent.
<iframe src="http://www.npr.org/player/embed/131536422/131546265" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Assistant Attorney General Tony West announces a drug industry settlement in September.
Manuel Balce Ceneta/AP
November 22, 2010 Assistant Attorney General Tony West says the law had become “one of our most successful civil enforcement tools,” allowing the Justice Department to recover billions that would have otherwise been lost in the system.
When kids are sneezing, watch the meds.
November 22, 2010 Less than half of the country's babies and toddlers are going to the ER for cold and cough medicine related problems now. But older kids ER visits for these problems remain unchanged.
November 19, 2010 A prescription painkiller on the market since the 1950s is being withdrawn after new data showed it raises the risks for irregular heart rhythms. Critics had long faulted the drug for being ineffective. Safety worries mounted recently.
November 17, 2010 A daily pill from Merck raised HDL cholesterol by 138 percent in people who got the medicine compared with those who didn't. The pill, which hasn't been approved by the Food and Drug Administration, also cut bad cholesterol by 38 percent.
November 9, 2010 New clinical data show a medicine called lorcaserin helped diabetics shed weight. But the losses were modest, and safety questions remains. So the medicine still faces a tough road at the Food and Drug Administration.
Glaxo's world headquarters in Brentford, Middlesex, U.K.
November 9, 2010 A former drug company lawyer allegedly obstructed a Food and Drug Administration investigation into the marketing of an antidepressant for unapproved uses. Doctors paid by the company allegedly promoted an antidepressant for weight loss.
November 8, 2010 Doctors are taking less money from industry than they did in 2004, a national survery finds. But it's still the case that most doctors have a financial relationship of some sort with industry. Free drug samples, food and drinks remain common.
November 8, 2010 A drug that costs $8 a day may be cheaper to use than an old generic that's only cost $1. Less stringent monitoring of patients on the newly approved drug is a big reason why, according to an independent analysis.
November 8, 2010 Human tests of an experimental medicine called tasocitinib show it works pretty well at managing rheumatoid arthritis symptoms. There are side effects, of course, including an increase in infections.
November 2, 2010 Pitney Bowes finds cutting copays for drugs to fight cholesterol and blood clots increased the likelihood people would take them as recommended. A study of the approach concludes the time is ripe for insurers and companies to cut some copays.
November 1, 2010 About 38,000 bottles of high-strength Lipitor are affected. A smelly chemical traced to wooden shipping pallets has contaminated some batches of the cholesterol-fighting pills.
Ghosts or medical writers?
October 29, 2010 Ever wondered about the folks who really write some of the biggest papers published in medical journals around the world? A ghostwriter sits down for a pre-Halloween chat about how the scientific sausage is made.
The menu may not have a new diet medicine anytime soon.
October 29, 2010 The Food and Drug Administration has a lot of questions about Qnexa, an experimental diet pill. Are the risks worth a modest improvement in weight loss? That remains the big bugaboo for the field of weight-loss medicines.
NPR thanks our sponsors
Become an NPR sponsor